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Abstract
The Treponema denticola ATCC 35405 genome annotation contains most of the
genes for de novo pyrimidine biosynthesis. To initiate characterization of pyrimi-
dine synthesis in Treponema, we focused on TDE2110 (the putative pyrF, encoding
orotidine-50-monophosphate decarboxlyase). Unlike the parent strain, an isogenic
pyrF mutant was resistant to 5-fluoroorotic acid. In complex medium, growth of
the pyrF mutant was independent of added uracil, indicating activity of a uracil
uptake/salvage pathway. Transcription of pyrF was greatly reduced in T. denticola
grown in excess uracil, demonstrating that de novo pyrimidine synthesis is
regulated and suggesting a feedback mechanism. Treponema denticola PyrF
complemented uracil auxotrophy in an Escherichia coli pyrF mutant. This study
provides biochemical confirmation of T. denticola genome predictions of de novo
and salvage pyrimidine pathways and provides proof of concept that pyrF has
potential as a selectable marker in T. denticola.
Introduction
Understanding of the basic biology, biochemistry and ge-
netics of spirochetes has lagged behind other more widely
studied pathogens, commensals and environmental micro-
organisms that are more readily cultivated. The advent of
whole genome sequencing has permitted characterization of
spirochete proteins and biochemical pathways including
both those that are universal or widespread in most organ-
isms (Figge & Cerff, 2001) as well as those that may be
unique to certain spirochetes (Kent et al., 2004). The
information revealed by genome sequencing provides a huge
amount of potentially important information that must at
some point be confirmed to both biochemical and biological
function. This requires generation of specific mutant strains
in which predicted biochemical pathways can be demon-
strated (White, 2006).
A survey of the Treponema denticola ATCC 35405 genome
identifies TDE2110 as pyrF/URA3, present in a single copy
in the genome. pyrF/URA3 genes encode orotidine-50-
phosphate (OMP) decarboxylase, which catalyzes a key step
in de novo pyrimidine biosynthesis, producing uridine
monophosphate (UMP). This pathway, highly conserved
from bacteria to humans, is a key source of pyrimidines as
DNA and RNA precursors, and also as precursors for the
synthesis of certain phospholipids, complex carbohydrates,
vitamins and glycoproteins. In addition to or in place of
de novo synthesis, many organisms also rely on exogenous
uracil in a salvage pathway for pyrimidine synthesis. Trepo-
nema denticola genes in the salvage pathway were recently
annotated in the genome sequence and include TDE1612
(upp, encoding uracil phosphoribosyltransferase), TDE2251
(uraA, uracil permease) and TDE1360 (xanthine/uracil
permease family protein). Interestingly, Treponema pallidum
has the genes for the salvage pathway including upp and
pyrH, but lacks pyrB-F required for de novo synthesis.
Regulation of pyrimidine synthesis has been studied
extensively for many years (reviewed in O’Donovan &
Neuhard, 1970), and different organisms show a range of
mechanisms regulation. In Escherichia coli, expression of
PyrC, D, E, F and G are repressed by uracil, while PyrA is
feedback-inhibited by UMP. In contrast, pyrimidine synth-
esis in Pseudomonas aeruginosa appears to be constitutive.
In yeast, uridine triphosphate simultaneously inhibits the
activities of PyrA- and PyrB-like enzymes by a feedback
inhibition mechanism. While a study by Ishihara et al.
(1992) identified a T. denticola gene encoding PyrB and
demonstrated its enzymatic activity in E. coli, there is no
information available on the rest of the de novo pyrimidine
synthesis pathway in this organism or on its regulation.
In T. denticola, defined mutants are currently made
by allelic replacement mutagenesis, a cumbersome, low-
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efficiency procedure. Genetic systems available in T. denti-
cola are limited owing to a paucity of selectable markers and
vectors (Li et al., 1996; Fenno et al., 1998; Chi et al., 1999;
Slivienski-Gebhardt et al., 2004). Genomic data suggest that
T. denticola possesses restriction systems that are very likely
active and detrimental to the introduction of exogenous
DNA. Taken together, these factors are a major obstacle to
molecular analysis of cultivable treponemes. In many organ-
isms, some of these limitations are overcome by use of
counterselectable markers that are recovered by a secondary
selection step following initial mutagenesis. These systems
not only permit construction of multiple mutations in
organisms with limited selectable markers but also permit
construction of defined unmarked mutations that are often
important for functional analysis of mutated genes.
Orotate phosphoribosyltransferase (PyrE) can incorpo-
rate the pyrimidine analog 5-fluoro-orotic acid (5-FOA) to
form 5-fluoro-orotylidate (5-F-OMP) instead of the normal
OMP. This product is then used as a substrate by the OMP
decarboxylase (PyrF), producing 5F-UMP instead of UMP.
While 5-FOA is not directly toxic, accumulation of 5F-
UMP-containing cellular components leads to cell death
due to severe toxicity. This feature is the basis for the URA3
(pyrF) selection system used widely in Saccharomyces cerevi-
siae for both positive and negative selection in URA3-
deficient strains (Boeke et al., 1984). This system has been
used rarely in other microorganisms, especially where other
selectable markers are available. However, in recent years,
pyrF-based counterselection methodology has been devel-
oped for a few bacteria in which other methods are
impracticable (Knipfer et al., 1997; Galvao & de Lorenzo,
2005) as well as for several genera of archaea (Peck et al.,
2000; Lucas et al., 2002; Bitan-Banin et al., 2003; Sato et al.,
2003).
To identify potential counterselectable markers for
T. denticola, we focused on TDE2110, (pyrF) present in only
a single copy in the genome. To determine whether
TDE2110 encodes a functional OMP decarboxylase, we
constructed and characterized 5-FOA resistance in a pyrF-
deleted strain and showed that T. denticola pyrF comple-
mented an E. coli pyrF mutant. Our results demonstrate the
presence of both de novo and salvage pyrimidine synthesis
pathways in T. denticola and provide proof of concept for
use of a T. denticola pyrF mutant as a host strain for pyrF-
based counterselection mutagenesis.
Materials and methods
Bacterial strains and growth conditions
Treponema denticola ATCC 35405 and isogenic mutants
were grown in NOS broth medium as described previously
(Haapasalo et al., 1991), with erythromycin (40mg mL1),
uracil (10 or 20 mg mL1) or 5-fluoroorotic acid (5-FOA,
Zymo Research, Orange, CA; 1–10 mM) added as appro-
priate. 5-FOA toxicity was assayed by its ability to inhibit
T. denticola growth in NOS medium. A stock solution of
5-FOA (50 mg mL1 in DMSO) was diluted serially in
DMSO and equal volumes of resulting 5-FOA solutions
(including DMSO alone as negative control) were added to
NOS medium. For growth studies, actively growing cultures
were diluted 1 : 100 in NOS with or without supplement of
interest and growth was monitored daily by OD at 600 nm
for up to 2 weeks, by which point cultures were in stationary
phase. Growth studies were conducted at least twice, with
triplicate samples. Cultures were examined by phase con-
trast microscopy for purity and typical strain morphology.
Escherichia coli NovaBlue (Novagen) and JM110 (Yanisch-
Perron et al., 1985), used as hosts for cloning and plasmid
preparations, were grown in Luria–Bertani (LB) broth or
agar medium supplemented with kanamycin (50mg mL1)
or erythromycin (200mg mL1) as appropriate. For growth
studies, E. coli YA149 carrying plasmids of interest was
grown in M9 minimal medium containing 20 mM CaCl2,
0.2% glucose, 0.1% glycerol, 0.1% casamino acids and
kanamycin (50mg mL1), with uracil (10mg mL1) or
5-FOA (5 mM) added as appropriate. Overnight cultures
grown in LB medium were diluted 1 : 500 in M9 medium
and incubated at 37 1C with shaking. Growth was monitored
by OD at 600 nm over a 10 h time course, by which point
cultures were in stationary phase.
Allelic replacement mutagenesis
For allelic replacement of T. denticola pyrF, a genomic DNA
fragment containing TDE2109-TDE2110-TDE2111 and
part of TDE2112 was amplified with primers CX421
(50-TTGCAGCATTTTTAGGCATAGTA-30) and CX422
(50-TCATACTTCTTCCTCTTTCCGTTT-30) and cloned in
plasmid vector pSTBlue-1 (Novagen). TDE2109 is anno-
tated as deaD, encoding an ATP-dependent RNA helicase.
TDE2111 encodes an uncharacterized Treponema-specific
protein. Both genes are transcribed away from pyrF. To
facilitate subsequent steps, this plasmid was then digested
with ScaI and then self-ligated to remove a small portion
of the vector, the 50 end of TDE2111 and the 30 end of
TDE2112. The resulting plasmid, digested with HindIII and
PpuMI to remove a 550 bp internal fragment of pyrF, was
treated with Klenow fragment of DNA polymerase to create
blunt ends and ligated to the ermF-ermB cassette from
pSY118 (Lee et al., 2002a), yielding pCF382. Plasmid
pCF382, with the ermF-ermB cassette in the same transcrip-
tional orientation as pyrF, was linearized with BsaBI and
EcoRI to remove vector DNA and then electroporated into
T. denticola as described previously (Li et al., 1996; Fenno
et al., 1998). Mutants were selected for resistance to
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erythromycin (EmR) in NOS/GN agar (Chan et al., 1997).
Mutations were verified by PCR analysis of the target region
in genomic DNA.
Transcription analysis
Total RNA was isolated from T. denticola cultures harvested
during logarithmic growth (3 days) using the RNeasy Mini
Kit (Qiagen). DNAse-treated RNA samples were reversed
transcribed with random hexamer primers using the Super-
ScriptTM First-Strand Synthesis System for reverse transcrip-
tase polymerase chain reaction (RT-PCR; Invitrogen). One
microlitre of the resulting first-strand cDNA was amplified
for 30 cycles using Taq DNA polymerase (Invitrogen), with
16S rRNA gene serving as an internal control for normal-
ization between samples. The GeneFisher algorithm (Gie-
gerich et al., 1996) was used to design gene-specific Tm-
matched primer sets yielding 80–120 bp amplicons. RT-PCR
products, including negative controls (no RT enzyme), were
analyzed by agarose gel electrophoresis.
Results and discussion
Overview of T. denticola pyrimidine synthesis
pathway
Genes encoding most enzymes required for de novo pyrimi-
dine synthesis have been provisionally identified in the
T. denticola genome (Seshadri et al., 2004) or in updated
annotations (http://www.oralgen.lanl.gov/). These include
pyrB, C, D, E and F (Table 1). Of these, only pyrB, encoding
aspartate carbamoyltransferase, has been functionally con-
firmed (Ishihara et al., 1992). Unlike many bacteria,
T. denticola does not appear to possess a glutamine-depen-
dent carbamoyl-phosphate synthase (PyrA). However, con-
sistent with its peptide-dependent metabolism (Mäkinen &
Mäkinen, 1996), T. denticola likely synthesizes carbamoyl
phosphate directly from NH3, CO2 and ATP by means of
carbamate kinase activity encoded by TDE2476 (arcC). It is
noteworthy that the T. denticola genes in the de novo
pyrimidine pathway do not appear to be linked at the level
of transcription. The two most closely located genes, pyrC
and pyrF, are transcribed in opposite directions and are
separated by two apparently unrelated genes. TDE1612,
recently annotated as upp, encodes uracil phosphoribosyl-
transferase activity required for one-step interconversion of
uracil and UMP in the salvage pathway. The alternative two-
step pathway (50-ribonucleotide phosphohydrolase followed
by uridine hydrolase) has not been identified in T. denticola
as of this writing. TDE2085 (pyrH) encodes a uridylate
kinase that catalyzes the same step in both the de novo and
salvage pathways. To date, no T. denticola gene encoding
nucleoside diphosphate kinase has been identified. In con-
trast, T. pallidum lacks all the genes for de novo pyrimidine
biosynthesis, and is thus reliant on its mammalian host for
uracil (Fraser et al., 1998).
Allelic replacement mutagenesis of T. denticola
pyrF
The T. denticola genome annotation identifies TDE2110 as
pyrF. The deduced polypeptide exhibits high homology
(BLAST score 4 200) with PyrF in a wide range of prokar-
yotic organisms. Interestingly, this list does not include PyrF
of E. coli and other enterics, and E. coli PyrF does not have a
homolog in T. denticola (data not shown). To demonstrate
that TDE2110 encodes OMP decarboxlyase, the key final
step in de novo synthesis of UMP, we constructed an isogenic
mutant by allelic replacement of TDE2110 with a gene
cassette encoding EmR (Fletcher et al., 1995). The strategy
for mutagenesis of pyrF is shown in Fig. 1. Positive EmR
clones resulting from double crossover homologous recom-
bination following electroporation with linearized pCF382
were verified by PCR using CX421 and CX422, as well as
primers specific for the ermF-ermB cassette and the deleted
portion of pyrF (data not shown). A validated pyrF-deleted
isolate designated T. denticola D2110E (for Deleted
TDE2110 with Erythromycin marker) was preserved for
further analysis.
Table 1. Treponema denticola pyrimidine biosynthesis genes
Gene ID Gene E.C. number Enzyme Product
TDE2476 arcC 2.7.2.2 Carbamate kinase Carbamoyl-phosphate
TDE0129 pyrB 2.1.3.2 Aspartate carbamoyltransferase N-carbamoyl-L-aspartate
TDE2107 pyrC 3.5.2.3 Dihydroorotase Dihydroorotate
TDE0982 pyrD 1.3.3.1 Dihydroorotate oxidase Orotate
TDE1001 pyrE 2.4.2.10 Orotate phosphoribosyltransferase Orotidine-5-phosphate
TDE2110 pyrF 4.1.1.23 Orotidine-50-P decarboxylase Uridine-5-phosphate
TDE2085 pyrH 2.7.4.22 Uridylate kinase Uridine diphosphate
TDE1612 Upp 2.4.2.9 Uracil phosphoribosyltransferase Uracil
arcC and pyrB-F encode enzymes in the de novo pathway. The upp product functions in the salvage pathway. The pyrH product functions in both
pathways.
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Effects of 5-FOA and uracil on T. denticola
growth
Because some T. denticola EmR mutant strains have been
shown to contain subpopulations of wildtype, spontaneous
point mutants to EmR (Lee et al., 2002b), we further
validated D2110E by comparing its growth on NOS-GN
agar containing both erythromycin and 5 mM 5-FOA to that
of 35405 grown on NOS-GN agar alone or with 5 mM
5-FOA. Strain D2110E grew in the presence of 5-FOA while
35405 did not (data not shown). To further characterize the
contribution of PyrF activity both to T. denticola growth and
to its sensitivity to the toxic metabolites of 5-FOA, two
growth studies were performed. Treponema denticola 35405
and D2110E were grown in the presence of a range of 5-FOA
concentrations (0, 1, 5 and 10 mM) and growth was
monitored for up to 2 weeks (Fig. 2a). 35405 did not grow
in NOS medium containing 1, 5 or 10 mM 5-FOA. D2110E
Fig. 1. Strategy for pyrF mutagenesis in Treponema denticola 35405. An isogenic T. denticola pyrF mutant was constructed as described in the text.
Treponema denticola was electroporated with a linear DNA fragment consisting of the nonvector portion of pCF382, in which ermF-ermB replaced a
550 bp internal fragment of pyrF. EmR strain T. denticola D2110E resulting from double crossover homologous recombination at pyrF-flanking regions




T. denticola strain  [5-FOA]  O.D.* 






























D2110E 0  0.305
 1 mM 0.371
 5 mM 0.250
 10 mM 0.032
* Optical density at 600 nm, stationary phase.
Fig. 2. Effects of 5-FOA and excess uracil on Treponema denticola growth. OD of T. denticola cultures was measured by absorbance at 600 nm. Results
of representative growth studies are shown. Sample variability (not shown) was not significant. (a) Growth of T. denticola 35405 was inhibited by 1 mM
5-FOA, while pyrF mutant D2110E grew in the presence of up to 5 mM 5-FOA. (b) Treponema denticola 35405 and D2110E growth in NOS medium or
NOS medium supplemented with 20 mg mL1 uracil.
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grew equally well in NOS alone or NOS supplemented with
1 or 5 mM 5-FOA, but did not grow in 10 mM 5-FOA. Next,
both strains were tested for growth in NOS with or without
additional uracil supplementation. Addition of up to
20 mg mL1 uracil had no significant effect on the growth of
either strain. As illustrated in Fig. 2b, T. denticola D2110E
grew at a slower rate and attained a lower final OD than
35405, independent of additional uracil. This indicates that
NOS medium contains sufficient uracil to sustain growth in
the absence of de novo pyrimidine synthesis. The difference
in growth rate is consistent with the considerably slower
appearance of D2110E colonies in semisolid medium (c. 3
weeks vs. 8–10 days for 35405, data not shown). Interest-
ingly, supplementation with excess uracil (20mg mL1)
resulted in decreased sensitivity of T. denticola 35405 to 5-
FOA (data not shown). Since both PyrE and PyrF activity
are required for 5-FOA toxicity, the lack of toxicity under
conditions of excess uracil likely reflects the activity of the
salvage pathway, and may be due in part to downregulation
of de novo pyrimidine synthesis when exogenous uracil is
available.
Transcription of T. denticola pyr genes in
response to uracil
In many bacterial systems, at least some of the pyr genes are
organized in an operon (Theisen et al., 1987; Ghim &
Neuhard, 1994). As shown in Table 1, this is not the case in
T. denticola. In both bacteria and yeast, pyrimidine synthesis
is regulated at the transcriptional level, by availability of
exogenous uracil or pyrimidine triphosphates (Bach et al.,
1979; West, 2005). Because PyrE and PyrF catalyze the two
final steps in UMP synthesis and are required for 5-FOA
toxicity, we focused on analysis of transcription of these
genes. We used RT-PCR to assay expression of pyrE, pyrF
and pyrH in T. denticola 35405 grown under conditions of
limited or excess uracil. As shown in Fig. 3, transcription of
pyrF was greatly reduced when grown in excess uracil. We
did not detect changes in pyrE transcription in response to
excess uracil. As expected, transcription of pyrH was not
affected by uracil because PyrH functions in both the
de novo and salvage pathways. It should be noted that NOS
broth is a complex medium containing yeast extract and
serum, and thus likely contains available uracil adequate for
T. denticola growth. Therefore, de novo pyrimidine synthesis
may be at less than maximum levels in this complex
medium. To date, there have been no reports of growth of
T. denticola in a chemically defined serum-free medium.
[Correction added 22 January 2007: A seminal paper by
Wyss (1992) reported growth of several T. denticola strains
(not including the type strain ATCC 35405) in chemically
defined serum-free OMIZ-W1 medium. A related study is
currently in press in this journal (Wyss, 2007).]
Complementation of E. coli pyrF mutant by
T. denticola pyrF
To confirm the identity and activity of PyrF, we introduced a
plasmid carrying T. denticola pyrF into E. coli pyrF mutant
YA149 (Beckwith et al., 1962). A derivative of pSTBlue-1 was
constructed in which the ermF-ermB cassette from pSY118
(Lee et al., 2002a) replaced the 30 end of the multiple cloning
site (MCS), the f1 phage origin and most of the bla gene of
pSTBlue-1. The constitutive fla promoter and ribosome
binding site (Pfla) from pBFC (Slivienski-Gebhardt et al.,
2004) was cloned in the MCS of the resulting plasmid.
T. denticola pyrF was amplified using primers complemen-
tary to the 50 and 30 ends of the ORF and cloned directly
downstream of Pfla. The resulting plasmid (pREM1; Fig. 4a)
contains T. denticola pyrF under transcriptional control of
Pfla. Plasmids pREM1 and pSTBlue-1 were maintained in
E. coli by selection with Km, as described in Materials and
methods. As shown in Fig. 4b, YA149/pSTBlue-1 growth in
modified M9 minimal medium was dependent on supple-
mentation with uracil (2mg mL1). YA149/pREM1 grew in
Fig. 3. Expression of pyrF mRNA is reduced in the presence of excess
uracil. Treponema denticola 35405 was grown in NOS medium ( ) or
NOS medium supplemented with 40mg mL1 uracil (1). RT-PCR results
from cells in logarithmic growth phase are shown. Primer sets are shown
in Table 2. 16S rRNA gene controls were conducted on templates
prepared with or without reverse transcriptase (RT). Results representa-
tive of three independent experiments are shown.








CX608 pyrE (F) AACCCTTTACTTGGGCATC
CX609 pyrE (R) ATTCGGGGTCAAAGTCAAC
CX610 pyrF (F) TTTTCGGGTTCCGAAAG
CX611 pyrF (R) GTCGAAGGCTTCGATAG
CX612 pyrH (F) GGCAAATACTGGTTGCTG
CX613 pyrH (R) TTAGGATCGTCGGTATAGAC
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minimal medium (with our without uracil) at a similar rate
and final OD as YA149/pSTBlue-1 grown with uracil. When
grown in LB broth, YA149/pSTBlue-1 was resistant to 5 mM
5-FOA, while YA149/pREM1 was unable to grow in the
presence of 5 mM 5-FOA when the plasmid was maintained
with kanamycin (data not shown).
Conclusions
Our findings demonstrate that T. denticola TDE2110 (pyrF)
encodes an active orotidine 50 phosphate decarboxylase
activity and that pyrF transcription is downregulated in
response to uracil availability. Mutagenesis of pyrF conferred
resistance to 5-FOA, and T. denticola pyrF complemented an
E. coli pyrF mutant. Our functional confirmation of
T. denticola pyrF annotation provides strong evidence of
both the de novo and salvage pathways for pyrimidine
biosynthesis. Viability of the T. denticola pyrF mutant
demonstrates that T. denticola possesses the salvage pathway
for pyrimidine biosynthesis, while its resistance to 5-FOA
confirms existence of the key enzymes PyrE and PyrF in the
de novo pathway. While pyrF is not an essential gene in
T. denticola, it appears to be necessary for optimal growth,
suggesting that the salvage pathway is relatively inefficient.
In contrast, T. pallidum appears to possess only the salvage
pathway and is thus reliant on the uptake of uracil from its
mammalian host. While the complex NOS medium used in
the present study was sufficient to detect the effects of large
excesses of uracil on pyrF transcription, we anticipate that
growth in the complete absence of uracil would result in
more dramatic changes in the transcription of pyrimidine
pathway genes. A partially defined medium for oral spir-
ochetes [OMIZ-P4 (Riviere et al., 1999; Coico et al., 2006);
ATCC Medium 2131] that is used by several laboratories
contains uracil, yeast extract and serum, and would likely
yield similar results. More complete characterization of
these pathways will require development of a chemically
defined serum-free minimal medium for T. denticola.
Construction and properties of T. denticola D2110E
provide proof of concept that a pyrF-based counter-selec-
tion mutagenesis system, such as is widely used in
S. cerevisiae, is feasible in T. denticola. Having determined
that it is not an essential gene, we are currently exploring use
of pyrF as a selectable marker for both positive and negative
selection in T. denticola. Because 5-FOA is toxic in the
presence of active PyrF, it should be possible to construct
an unmarked pyrF deletion mutant by allelic replacement
and direct selection with 5-FOA without antibiotic selection.
Plasmid pREM1 could then be used as a vector for two-
step counterselection mutagenesis, resulting in defined,
unmarked chromosomal mutations.
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